![Alkermes plc logo](/logos/ALKS.webp)
Alkermes plc
NASDAQ:ALKS
Overview | Financials
Company Name | Alkermes plc |
Symbol | ALKS |
Currency | USD |
Price | 26.86 |
Market Cap | 4,422,982,480 |
Dividend Yield | 0% |
52-week-range | 22.01 - 32.88 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Richard F. Pops |
Website | https://www.alkermes.com |
An error occurred while fetching data.
About Alkermes plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD